Table 2: Number and proportion of prostate biopsies that showed malignant disease, 1992-2012
YearAge group, no. (%)Cancer, %Cancer, no.Biopsy, no.
40-4950-5960-6970-7980-89≥ 90
199210
(7.4)
124
(15.3)
612
(23.4)
677
(31.4)
171
(32.2)
7
(38.9)
25.616016263
199312
(7.1)
195
(18.2)
841
(26.4)
784
(31.5)
197
(38.2)
8
(44.4)
27.320377456
199423
(12.0)
268
(22.6)
912
(27.8)
786
(33.1)
178
(36.9)
3
(15.8)
28.821707541
199519
(10.1)
256
(23.1)
846
(28.6)
777
(36.0)
152
(41.0)
7
(43.8)
30.320576801
199631
(15.5)
318
(24.9)
1017
(31.6)
886
(37.7)
163
(40.8)
6
(54.6)
32.424217462
199732
(14.4)
413
(25.3)
1123
(29.8)
1058
(37.8)
180
(39.0)
7
(46.7)
31.628138897
199837
(14.8)
424
(26.1)
1176
(33.7)
1037
(40.0)
228
(43.1)
6
(50.0)
34.229088494
199951
(20.6)
481
(27.6)
1240
(36.3)
1088
(43.1)
212
(45.4)
17
(54.8)
36.730898424
200061
(19.4)
607
(30.8)
1455
(38.6)
1299
(46.4)
270
(53.6)
10
(50.0)
39.537029378
200172
(18.6)
763
(30.1)
1712
(39.3)
1447
(47.8)
314
(50.8)
9
(39.1)
39.4431710 955
200288
(23.7)
717
(29.0)
1573
(38.0)
1313
(46.5)
280
(48.5)
10
(55.6)
38.3398110 401
200384
(21.2)
728
(28.1)
1533
(37.2)
1216
(44.5)
284
(50.8)
6
(31.6)
37385110 416
2004105
(25.2)
969
(33.9)
1701
(39.7)
1399
(50.4)
314
(56.9)
10
(52.6)
41.2449810 909
2005136
(26.2)
1067
(32.8)
2039
(40.6)
1525
(49.6)
367
(58.6)
11
(55.0)
41.1514512 515
2006149
(25.4)
1226
(34.4)
2305
(43.1)
1623
(52.1)
336
(55.5)
20
(60.6)
42.7565913 255
2007155
(27.3)
1312
(35.2)
2484
(43.6)
1631
(51.2)
383
(61.7)
14
(73.7)
43.3597913 823
2008171
(28.6)
1325
(39.5)
2354
(46.6)
1612
(57.3)
347
(62.9)
13
(86.7)
47582212 383
2009166
(27.6)
1322
(38.1)
2526
(47.4)
1604
(58.4)
369
(70.4)
8
(61.5)
47.3599512 684
2010178
(31.1)
1272
(39.7)
2546
(48.8)
1625
(60.3)
395
(74.3)
10
(71.4)
49.2602612 239
2011169
(30.7)
1261
(37.6)
2544
(46.7)
1600
(58.4)
364
(68.8)
18
(78.3)
47.1595612 650
2012107
(24.4)
890
(33.3)
1795
(1.0)
1066
(48.7)
254
(56.8)
10
(62.5)
40.6412210 149
Mean for study period88
(20.5)
759
(29.8)
1635
(37.5)
1241
(45.8)
274
(51.7)
10
(53.7)
38.1400710 147